Tougeron D - Search Results

1

Epidermal growth factor receptor (EGFR) and KRAS mutations during chemotherapy plus anti-EGFR monoclonal antibody treatment in metastatic colorectal cancer.

Tougeron D, Cortes U, Ferru A, Villalva C, Silvain C, Tourani JM, Levillain P, Karayan-Tapon L. Tougeron D, et al. Cancer Chemother Pharmacol. 2013 Aug;72(2):397-403. doi: 10.1007/s00280-013-2211-0. Epub 2013 Jun 14. Cancer Chemother Pharmacol. 2013. PMID: 23765179

2

Safety and outcome of definitive chemoradiotherapy in elderly patients with oesophageal cancer.

Tougeron D, Di Fiore F, Thureau S, Berbera N, Iwanicki-Caron I, Hamidou H, Paillot B, Michel P. Tougeron D, et al. Br J Cancer. 2008 Nov 18;99(10):1586-92. doi: 10.1038/sj.bjc.6604749. Epub 2008 Oct 28. Br J Cancer. 2008. PMID: 19002180 Free PMC article.

3

TP53 mutations predict disease control in metastatic colorectal cancer treated with cetuximab-based chemotherapy.

Oden-Gangloff A, Di Fiore F, Bibeau F, Lamy A, Bougeard G, Charbonnier F, Blanchard F, Tougeron D, Ychou M, Boissière F, Le Pessot F, Sabourin JC, Tuech JJ, Michel P, Frebourg T. Oden-Gangloff A, et al. Among authors: tougeron d. Br J Cancer. 2009 Apr 21;100(8):1330-5. doi: 10.1038/sj.bjc.6605008. Br J Cancer. 2009. PMID: 19367287 Free PMC article.

4

Esophageal cancer in the elderly: an analysis of the factors associated with treatment decisions and outcomes.

Tougeron D, Hamidou H, Scotté M, Di Fiore F, Antonietti M, Paillot B, Michel P. Tougeron D, et al. BMC Cancer. 2010 Sep 24;10:510. doi: 10.1186/1471-2407-10-510. BMC Cancer. 2010. PMID: 20868479 Free PMC article.

5

Hyperkeratotic eczema of the nipple and areola associated with sorafenib treatment.

Tougeron D, Wierzbicka-Hainaut E, Osdoit S, Chagneau-Derrode C, Yacoub M, Silvain C. Tougeron D, et al. Eur J Dermatol. 2010 Nov-Dec;20(6):854-6. doi: 10.1684/ejd.2010.1123. Epub 2010 Oct 18. Eur J Dermatol. 2010. PMID: 20956109 No abstract available.

6

Management of esophageal adenocarcinoma.

Tougeron D, Richer JP, Silvain C. Tougeron D, et al. J Visc Surg. 2011 Jun;148(3):e161-70. doi: 10.1016/j.jviscsurg.2011.05.008. Epub 2011 Jun 28. J Visc Surg. 2011. PMID: 21715236 Free article. Review.

7

Safety and outcome of chemoradiotherapy in elderly patients with rectal cancer: results from two French tertiary centres.

Tougeron D, Roullet B, Paillot B, Hamidou H, Tourani JM, Bensadoun RJ, Michel P, Silvain C. Tougeron D, et al. Dig Liver Dis. 2012 Apr;44(4):350-4. doi: 10.1016/j.dld.2011.10.017. Epub 2011 Nov 25. Dig Liver Dis. 2012. PMID: 22119617

8

Effect of low-frequency KRAS mutations on the response to anti-EGFR therapy in metastatic colorectal cancer.

Tougeron D, Lecomte T, Pagès JC, Villalva C, Collin C, Ferru A, Tourani JM, Silvain C, Levillain P, Karayan-Tapon L. Tougeron D, et al. Ann Oncol. 2013 May;24(5):1267-73. doi: 10.1093/annonc/mds620. Epub 2013 Jan 4. Ann Oncol. 2013. PMID: 23293113 Free article.

9

[Immune response and colorectal cancer].

Tougeron D, Fauquembergue E, Latouche JB. Tougeron D, et al. Bull Cancer. 2013 Mar;100(3):283-94. doi: 10.1684/bdc.2013.1716. Bull Cancer. 2013. PMID: 23501583 Review. French.

10

Genetic variations of the A13/A14 repeat located within the EGFR 3' untranslated region have no oncogenic effect in patients with colorectal cancer.

Sarafan-Vasseur N, Sefrioui D, Tougeron D, Lamy A, Blanchard F, Le Pessot F, Di Fiore F, Michel P, Bézieau S, Latouche JB, Frebourg T, Sesboüé R. Sarafan-Vasseur N, et al. Among authors: tougeron d. BMC Cancer. 2013 Apr 8;13:183. doi: 10.1186/1471-2407-13-183. BMC Cancer. 2013. PMID: 23565769 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

217 results

Search Page